Front Row Advisors’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.5K Hold
150
0.02% 232
2025
Q4
$29K Hold
150
0.01% 271
2025
Q3
$20.6K Buy
+150
New +$16.4K 0.01% 307
2024
Q3
Sell
-100
Closed -$14.8K 808
2024
Q2
$14.8K Hold
100
0.01% 486
2024
Q1
$11.3K Buy
+100
New +$10.4K ﹤0.01% 555
2023
Q4
Sell
-100
Closed -$10K 775
2023
Q3
$10K Hold
100
﹤0.01% 518
2023
Q2
$11K Hold
100
﹤0.01% 509
2023
Q1
$11K Hold
100
0.01% 510
2022
Q4
$9K Hold
100
﹤0.01% 527
2022
Q3
$8K Hold
100
﹤0.01% 548
2022
Q2
$9K Hold
100
﹤0.01% 540
2022
Q1
$12K Hold
100
﹤0.01% 525
2021
Q4
$16K Hold
100
0.01% 474
2021
Q3
$11K Hold
100
﹤0.01% 546
2021
Q2
$11K Hold
100
﹤0.01% 548
2021
Q1
$12K Hold
100
0.01% 520
2020
Q4
$12K Hold
100
0.01% 480
2020
Q3
$11K Hold
100
0.01% 497
2020
Q2
$8K Sell
100
-45
-31% -$3.02K 0.01% 532
2020
Q1
$9K Hold
145
0.01% 494
2019
Q4
$10K Hold
145
0.01% 458
2019
Q3
$8K Hold
145
0.01% 494
2019
Q2
$7K Hold
145
0.01% 521
2019
Q1
$6K Hold
145
﹤0.01% 550
2018
Q4
$5K Hold
145
﹤0.01% 555
2018
Q3
$4 Hold
145
﹤0.01% 641
2018
Q2
$6 Hold
145
﹤0.01% 562
2018
Q1
$7K Sell
145
-62
-30% -$2.84K ﹤0.01% 504
2017
Q4
$9K Buy
+207
New +$8.54K 0.01% 456

Other funds holding TER

Front Row Advisors's TER Position: Q1 2026 in Review

Front Row Advisors held its Teradyne (TER) position steady in Q1 2026 at 150 shares worth $44.5K. The position accounts for 0.02% of the portfolio, ranked #232.

Front Row Advisors first reported a position in TER in Q4 2017 and has held it in 29 quarters since. 1,223 funds tracked by Wall St. Rank hold TER as of Q1 2026.

  • Front Row Advisors held 150 shares of Teradyne worth $44.5K as of Q1 2026.
  • Front Row Advisors left its Teradyne share count unchanged in Q1 2026.
  • Teradyne made up 0.02% of Front Row Advisors's portfolio in Q1 2026, its #232 holding.
  • Front Row Advisors first reported a position in Teradyne in Q4 2017 and has held it in 29 quarters since.
  • 1,223 funds tracked by Wall St. Rank held Teradyne as of Q1 2026.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.